P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D-RD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): UPDATED ANALYSIS OF THE PHASE 3 MAIA STUDY.

Authors :: Weisel, K.
Kumar, S.
Moreau, P.
Bahlis, N.
Facon, T.
Plesner, T.
Orlowski, R.
Basu, S.
Nahi, H.
Hulin, C.
Quach, H.
Goldschmidt, H.
O'Dwyer, M.
Perrot, A.
Venner, C.
Raje, N.
Tiab1, M.
Macro, M.
Frenzel, L.
Leleu, X.
Source :: HemaSphere; May2023 Supplement S2, Vol. 7, p14-15, 2p
Publication Year :: 2023

Full Text Access

Tools